NasdaqGS - Nasdaq Real Time Price USD

Design Therapeutics, Inc. (DSGN)

3.5300
+0.0200
+(0.57%)
At close: 4:00:01 PM EDT
3.5300
0.00
(0.00%)
After hours: 4:05:14 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
68,401
62,383
78,190
67,593
35,831
Operating Income
-68,401
-62,383
-78,190
-67,593
-35,831
Net Non Operating Interest Income Expense
--
12,795
11,328
--
--
Other Income Expense
2,295
--
11,328
4,285
298
Pretax Income
-56,198
-49,588
-66,862
-63,308
-35,533
Net Income Common Stockholders
-56,198
-49,588
-66,862
-63,308
-35,533
Diluted NI Available to Com Stockholders
-56,198
-49,588
-66,862
-63,308
-35,533
Basic EPS
-0.99
--
-1.19
-1.14
-0.77
Diluted EPS
-0.99
--
-1.19
-1.14
-0.77
Basic Average Shares
56,654.4670
--
55,984.6700
55,707.5170
45,936.2350
Diluted Average Shares
56,654.4670
--
55,984.6700
55,707.5170
45,936.2350
Total Operating Income as Reported
-68,401
-62,383
-78,190
-67,593
-35,831
Total Expenses
68,401
62,383
78,190
67,593
35,831
Net Income from Continuing & Discontinued Operation
-56,198
-49,588
-66,862
-63,308
-35,533
Normalized Income
-56,198
-49,588
-66,862
-63,308
-35,533
Interest Income
--
12,795
11,328
--
--
Net Interest Income
--
12,795
11,328
--
--
EBIT
-68,401
-62,383
-78,190
-67,593
-35,831
EBITDA
-67,789
-61,787
-77,653
-67,187
-35,702
Reconciled Depreciation
612
596
537
406
129
Net Income from Continuing Operation Net Minority Interest
-56,198
-49,588
-66,862
-63,308
-35,533
Normalized EBITDA
-67,789
-61,787
-77,653
-67,187
-35,702
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CGEM Cullinan Therapeutics, Inc.
7.71
+2.80%
 
IKNA Ikena Oncology, Inc.
1.1100
0.00%
 
GLUE Monte Rosa Therapeutics, Inc.
4.1100
+3.27%
 
ERAS Erasca, Inc.
1.2300
-4.28%
 
IMCR Immunocore Holdings plc
31.00
+2.07%
 
EWTX Edgewise Therapeutics, Inc.
14.79
+0.07%
 
ORIC ORIC Pharmaceuticals, Inc.
5.14
+8.67%
 
LYEL Lyell Immunopharma, Inc.
0.4131
-0.46%
 
OLMA Olema Pharmaceuticals, Inc.
4.8000
+1.91%
 
PEPG PepGen Inc.
1.4900
-3.25%